MARKET WIRE NEWS
  1. Home
  2. Stock
  3. BPTSY
  4. News
  5. Biophytis Unveils Outlook Strategies For 2025 To Lau
BPTSY
Quote
Short
News
Articles
Message Board

Biophytis unveils outlook strategies for 2025, to launch phase 3 of SARA clinical program

Source: SeekingAlpha

2025-02-11 04:43:13 ET

More on Biophytis

Read the full article on Seeking Alpha

For further details see:

Biophytis unveils outlook strategies for 2025, to launch phase 3 of SARA clinical program
Biophytis SA

NASDAQ: BPTSY

BPTSY Trading

0.0% G/L:

$0.45 Last:

500 Volume:

$0.45 Open:

mwn-link-x Ad 300

BPTSY Latest News

April 22, 2025 01:00:00 am
Biophytis Targets Mobility Restoration in Patients with Obesity
April 14, 2025 07:00:42 am
Expected US Company Earnings on Monday, April 14th, 2025
April 14, 2025 05:31:15 am
Expected earnings - Biophytis SA
April 09, 2025 01:30:00 am
Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity

BPTSY Stock Data

$143,252
273,726
N/A
1
368955%
Biotechnology & Life Sciences
Healthcare
https://www.biophytis.com
FR
Paris

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App